[BrokerRatings]Analyst Ratings Spotlight: Tech and Biotech Lead Strong Buys

Technology/Software leads the charge with 5 stocks (ADSK, MDB, AMBA) recently rated strong buy by analysts on Friday and Thursday. Retail (DLTR, FIVE) and Biotech (BMEA, NVAX) also saw notable upgrades. High target prices for ADSK ($380) and MDB ($430) suggest robust upside. However, recent downgrades in other tech and consumer names signal selective caution.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top